Teva’s Layoffs Signal Deeper Fault Lines In The Pharmaceutical Business Model Posted on June 2, 2025June 2, 2025 Teva’s layoffs highlight a stark reality: generic drugs no longer offer a reliable path to growth in the U.S. market.